FACTORS ASSOCIATED WITH DEVELOPMENT OF MENTAL ILLNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A POPULATION-BASED STUDY

被引：0
|
作者：
Chen, H. H. [1 ,2 ]
Chao, W. C. [1 ,3 ]
机构：
[1] Natl Chung Hsing Univ, Dept Postbaccalaureate Med, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Dept Crit Care Med, Taichung, Taiwan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Targeted synthetic drugs; bDMARD; Mental health;
D O I：
10.1136/annrheumdis-2023-eular.1176
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0289
引用
收藏
页码：1326 / 1326
页数：1
相关论文
共 50 条
  • [1] The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
    Gregory, Fleury
    Sylvano, Mania
    Didier, Hannouche
    Cem, Gabay
    SWISS MEDICAL WEEKLY, 2017, 147
  • [2] Patterns of Fatigue in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
    Freites Nunez, Dalifer
    Leon, Leticia
    Redondo, Marta
    Vadillo Font, Cristina
    Lois, Pia
    Mucientes Ruiz, Arkaitz
    Rodriguez-Rodriguez, Luis
    Fernandez Gutierrez, Benjamin
    Jover Jover, Juan Angel
    Abasolo Alcazar, Lydia
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] Combination of Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis
    Ribeiro, Andre Lucas
    Abarza, Virginia Carrizo
    Gladman, Dafna
    Chandran, Vinod
    Eder, Lihi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4728 - 4730
  • [4] PREDICTORS OF FATIGUE IN RHEUMATOID ARTHRITIS PATIENTSWHO RECEIVE BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Freites Nunez, Dalifer
    Redondo, Marta
    Abasolo, Lydia
    Lois, Pia
    Hernandez, Isabel
    Vadillo, Cristina
    Leon, Leticia
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1579 - 1580
  • [5] FATIGUE PATTERNS IN RHEUMATOID ARTHRITIS PATIENTSWHO RECEIVE BIOLOGICAL AND TARGETED SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Freites Nunez, Dalifer
    Redondo, Marta
    Font, Judit
    Madrid Garcia, Alfredo
    Vadillo, Cristina
    Abasolo, Lydia
    Leon, Leticia
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1618 - 1619
  • [6] Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide, population-based cohort study
    Kao, Chung-Mao
    Chen, Yen-Ju
    Chen, Yi-Ming
    Chen, Der-Yuan
    Chen, Hsin-Hua
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2025, 17
  • [7] Factors Associated with the Use of Biologic Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis
    Hosseini, Roya
    Fawaz, Souhiela
    Seoane-Vazquez, Enrique
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2595 - 2595
  • [8] FACTORS ASSOCIATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS UTILIZATION IN RHEUMATOID ARTHRITIS PATIENTS
    Hosseini, R.
    Brown, L.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2022, 25 (07) : S453 - S453
  • [9] Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis
    Martinez-Mugica, Cristina
    Salgueiro, Esther
    FARMACIA HOSPITALARIA, 2022, 46 (01) : 15 - 20
  • [10] TIME TO AND FACTORS ASSOCIATED WITH INITIATION OF BIOLOGICAL THERAPY WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN COLOMBIA
    Machado-Alba, J. E.
    Calvo-Torres, L. F.
    Banol-Giraldo, A. M.
    Garcia-Betancurt, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 514 - 514
12345